This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2022.
Company Filing History:
1 out of 834,350 Years Active: 2022
Title: **Profile of Inventor Canxin Xu**
Introduction
Canxin Xu is an innovative inventor based in Ballwin, Missouri, USA. He has made significant contributions to the field of pharmaceuticals through his inventive work in developing new compounds.
Latest Patents
Canxin Xu holds a patent for his invention titled "Substituted pyrrolopyridines as JAK inhibitors." This patent includes novel pyrrolopyridine compounds characterized by specific structural formulas, which are defined in detail. The application of these compounds extends to pharmaceutical compositions aimed at treating various diseases, including pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo, and psoriasis. Additionally, this invention provides methods for inhibiting JAK kinase activity in both human and animal subjects.
Career Highlights
Throughout his career, Canxin Xu has demonstrated expertise and a strong commitment to advancing medical treatments. His research has led to the development of cutting-edge solutions that aim to improve patient outcomes through innovative drug therapies.
Collaborations
Canxin has had the opportunity to work alongside talented individuals such as Eric Jon Jacobsen and David R Anderson. These collaborations highlight the importance of teamwork and shared knowledge in the development of new medical innovations.
Conclusion
With a focus on enhancing therapeutic options for complex diseases, Canxin Xu’s patent reflects his dedication to the field of pharmaceutical innovations. His work contributes to a broader understanding of JAK inhibitors and their potential in treating a variety of conditions, underscoring the importance of creativity and research in medicine.